Search Orphan Drug Designations and Approvals
-
Generic Name: | 6'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-paromamine sulfate |
---|---|
Date Designated: | 07/31/2020 |
Orphan Designation: | Treatment of cystic fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ELOXX Pharmaceuticals, Inc. 950 Winter Street Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-